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A b s t r a c t  
Starting from different ketones 1a-1f, aldehyde 2a-2g, and acetonitriles 3a-3d we synthesize some 
bioactive β- Acetamido carbonyl compounds 4a-4h. We also attempted to synthesize these 
compounds by using phenylacetone and deoxybenzoins in place of ketones to afford the products 
4i-4j. 1H-NMR spectra are presented. On the basis of QSAR studies, some compounds were tested 
for their anti-thrombotic activity in mice. Compound 4f, 4h and 4j were found to exhibit less 
percentage protection. 
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Introduction 
During the past few years, multicomponent reactions (MCRs) have 
proved to be remarkably successful in generating molecular 
complexity in a single synthetic-step operation [1-4]. These 
processes consist of two or more synthetic steps, which are 
performed without isolation of any intermediates, thus reducing 
time and saving both energy and raw materials. MCRs are 
powerful tools in modern drug-discovery processes and allow fast, 
automated, and high-throughput generation of organic compounds 
[5]. 
Multicomponent reactions (MCRs) are important for the 
achievement of high levels of diversity, as they allow more than two 
building blocks to be combined in practical, time-saving one-pot 
operations, giving rise to complex structures by simultaneous 
formation of two or more bonds, according to the domino principle 
[6]. MCRs contribute to the requirements of an environmentally 
friendly process by reducing the number of synthetic steps, energy 
consumption and waste production. Researchers have transformed 
this powerful technology into one of the most efficient and 
economic tools for combinatorial and parallel synthesis [7]. Due to 
their inherent simple experimental procedures and their one pot 
character, they are perfectly suited for automated synthesis. Multi-
component, one-pot syntheses are also highly important because 
of their wide range of applications in pharmaceutical chemistry for 
production of structural scaffolds and combinatorial libraries for 
preparation of drug-like molecules with several levels of structural 
diversity [8,9].  
β- Acetamido ketones and esters are valuable building blocks for a 
number of biologically and pharmaceutically bioactive important 
compounds [10,11]. They could easily be converted to 1, 3-amino 
alcohols, which are precursors for the synthesis of several 
antibiotics such as nikkomycins or neopolyoxins [12]. Furthermore, 
a field of increasing interest is the synthesis of useful synthetic 
building blocks via MCR chemistry. For this reason, the discovery 
of novel MCRs is of interest [13-15]. 
Devising reactions that achieve multi-bond formation in one step 
operation is becoming one of the major challenges in 
stepeconomic synthesis. As an enabling technology, 
multicomponent reactions (MCRs) make it possible to access 
target molecules with greater efficiency and atom economy [16].  
Materials and Methods 
All chemicals used in this research were purchased from sigma 
aldrich. The melting points of the synthesized compounds were 
measured with melting point analyzer Mel-Tem II. 1H NMR and 13C 
NMR spectra were run on Bruker Advance DPX 200/300 MHz 
spectrometer in CDCl3 unless stated otherwise and TMS was used 
as internal standard. Silica gel 60ă120 mesh was used as 
stationary phase to isolate the compounds. 
Experimental Procedure 
We developed a new synthetic methodology for the synthesis of β-
acetamido carbonyl compounds using BF3.OEt2 as a reagent. 
Initially, we attempted the reaction between p-hydroxy 
acetophenone, p-hydroxy benzaldehyde and acetonitrile using 
BF3.OEt2 and successfully synthesized our desired compound 
(Scheme 1). 
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Scheme 1  
 
 
Encouraged by the results, we used different ketones 1a-1f, 
aldehyde 2a-2g, and acetonitriles 3a-3d to synthesize more 
analogues and were succeeded to afford our desired products 4a-
4h. We also attempted to synthesize these compounds by using 
phenylacetone and deoxybenzoins in place of ketones to afford the 
products 4i-4j (Scheme 2). 
 
Scheme 2  
 
 
 
All synthesized compounds were characterized by 1H and 13C-
NMR and Mass spectroscopy. All the results are summarized in the 
Table 1. 
General procedure for the synthesis of β- Acetamido 
ketones (4a-4j) 
Ketone and aldehyde (1:1 equivalent) are dissolved in acetonitrile. 
BF3.OEt2 was added to the reaction mixture. The reaction was 
refluxed for 3-6 hrs at 70-80■C depending upon the reactants. The 
reaction was monitored by TLC.  Acetonitrile was evaporated in the 
rotary evaporator. Ethyl acetate was added to this crude mixture 
and washed it with water for 2-3 times. The organic layer was dried 
over sodium sulphate and evaporates it under the reduced 
pressure. Purification of the compounds was carried out with silica 
gel column chromatography.  
N-[1,3-bis(4-hydroxyphenyl)-3-oxopropyl]acetamide (4a) 
 Yield: 96%; m.p. 102■C;  1HNMR (400 MHz, CDCl3): 5.45(s,1H), 
6.74-6.77(d,2H), 6.85-6.88(d,2H), 7.19-7.22(d,2H), 7.80-
7.92(m,5H) 
  
N-[1,3-bis(4-hydroxyphenyl)-3-oxopropyl]-2-
(naphthalen-1-yl)acetamide (4b) 
 Yield: 94%; m.p. 145■C; 1H NMR (400 MHz, CDCl3):: 3.3-
3.5(m,2H), 4.00(s,2H), 5.50(s, 1H), 6.71-6.87(m,4H), 7.12-
7.16(d,2H), 7.40-7.50(m,4H), 7.80-7.92(s,5H) 
N-[1,3-bis(4-hydroxyphenyl)-3-oxopropyl]prop-2-
enamide (4c) 
 Yield: 92%; m.p. 137■C; 1H NMR (400 MHz, CDCl3):: 3.33-
3.58(m,2H), 5.51-5.55(t,1H), 5.61-5.65(m,1H), 6.21-6.26(t,2H), 
6.74-6.76(d,2H), 6.83-6.86(d,2H), 7.19-7.22(d,2H), 7.86-7.89(d,2H) 
N-[(1E)-5-(4-hydroxyphenyl)-5-oxo-1-phenylpent-1-en-
3-yl]acetamide (4d) 
 Yield: 93%; m.p. 150■C; 1H NMR (400 MHz, CDCl3):: 1.95(s,3H), 
3.23-3.41(m,3H), 4.89-5.09(t,1H), 6.21-6.32(m,1H), 6.49-
6.57(d,1H), 6.83-6.89(m,2H), 7.18-7.37(m,5H), 7.89-7.90(d,2H) 
N-[(4E)-1-(4-hydroxyphenyl)-4-methyl-1-oxohept-4-en-
3-yl]acetamide (4e) 
 Yield: 90%; m.p. 140■C; 1H NMR (400 MHz, CDCl3):: 1.25(s,5H), 
1.63(s,4H), 2.00(s,5H), 3.04-3.26(m,2H), 4.80(s,1H), 5.32(s,1H), 
6.52(s,1H), 6.84-6.87(d,2H), 7.81-7.85(d,2H) 
N-[1-(5-bromo-2-methoxyphenyl)-3-(3,4-
dichlorophenyl)-3-oxopropyl]-2-cyanoacetamide (4f) 
 Yield: 89%; m.p. 180■C; 1H NMR (400 MHz, CDCl3): 3.12-
3.16(d,2H), 3.68(s,2H), 3.79-3.81(d,3H), 5.73(s,1H), 6.99-
7.46(m,6H), 8.15(s,1H) 
N-[(5-chloro-2-nitrophenyl)(2,6-
dioxocyclohexyl)methyl]acetamide (4g) 
 Yield: 85%; m.p. 145■C; 1H NMR (400 MHz, CDCl3):: 1.78-
1.82(t,2H), 1.9(s,3H), 2.31(s,3H), 2.49-2.50(m,4H), 5.27(s,1H), 
6.35-6.37(d,1H), 7.32-7.35(d,1H), 7.75-7.78(d,1H), 7.85-
7.89(m,1H), 8.42-8.43(d,1H) 
N-[(4-cyanophenyl)(4,4-dimethyl-2,6-
dioxocyclohexyl)methyl]acetamide (4h) 
 Yield: 92%; m.p. 105■C; 1H NMR (400 MHz, CDCl3):: 0.99(s,6H), 
2.09(s,3H), 2.25(s,4H), 6.37-6.41(d,1H), 7.40-7.43(d,2H), 7.49-
7.52(d,2H), 8.25-8.28(d,1H) 
N-[1-(4-hydroxyphenyl)-3-oxo-2-phenylbutyl]acetamide 
(4i) 
 Yield: 86%; m.p. 112■C; 1H NMR (400 MHz, CDCl3):: 1.63(s,2H), 
1.93(s,4H), 2.15(s,3H), 3.34-3.38(m,1H), 4.25-4.30(d,1H), 4.37-
4.43(d,1H), 4.67(s,1H), 5.46-5.51(d,1H), 5.63-5.69(d,1H), 6.54-
6.58(d,2H), 6.76-6.80(d,2H), 6.94-6.98(d,2H), 7.12-7.44(m,9H) 
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N-[1-(3,4-dichlorophenyl)-3-(4-methoxyphenyl)-3-oxo-2-
phenylbutan-2-yl]-2-(naphthalen-1-yl)acetamide (4j) 
 Yield: 90%; m.p. 107■C;  13C NMR (400 MHz, CDCl3): 30.3, 42.3, 
56.0, 56.8, 164.4, 171.4, 124.5, 127.5, 129.4, 131.6, 136.2, 141.8 
Results and Discussion 
Conventional methods were used to carry out all the reaction 
steps. BF3/Et2O was used as catalyst to synthesize various β-
Acetamido ketones derivatives (4a-4j). The desired compounds 
were prepared using ketone (1 equi.)  and aldehyde (1 equi.), 
BF3.OEt2 in acetonitrile solvent under reflux at 70-80■C for 3-6 hrs. 
Various β-acetamido ketones derivatives were synthesized using 
different substituted aldehydes (1a-1f), ketones (2a-2g) and 
acetonitrile (3a-3b) using optimized reaction conditions. The results 
are summarized in Table 1. The yields obtained were ranging from 
85% to 96%.  
Few compounds were tested for their antithrombotic activity in 
mice. Clopidogrel was taken as a standard oral anti-platelet drug 
which shows 60% inhibition in mice. Compound 4f, 4h and 4j were 
tested and found exhibiting less % protection which is 20, 22 and 
10% respectively. Results are summarized in Table 2. 
 
Table 2: Antithrombotic activity results in mice 
S. No. Compounds % Protection
1 4f 20
2 4h 22
3 4j 10
4 Clopidogrel 60
Conclusion 
We have developed an efficient and improved three-component 
coupling reaction for the synthesis of β- Acetamido carbonyl 
compounds. The method offers several advantages such as short 
reaction times, simple reaction conditions and tolerance to a wide 
variety of reactants. 
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